[ Price : $8.95]
FDA grants AstraZenenca an accelerated approval for Etcamah (camizestrant), an estrogen receptor antagonist, in combination with a...[ Price : $8.95]
FDA approves Ionis Pharmaceuticals Zanvastro (zilganersen) injection for treating Alexander disease in pediatric and adult patient...[ Price : $8.95]
A Crowell & Moring analysis says FDA may increase regulatory scrutiny for user-facing GenAI-enabled devices.[ Price : $8.95]
FDA says helping to increase supplies of estradiol transdermal patches after reports that some patients are having difficulty find...[ Price : $8.95]
Four FDA senior officials explain how the agency is strengthening its good clinical practice oversight in an increasingly globaliz...[ Price : $8.95]
FDA publishes a request for information on stakeholders views on ways to accelerate botanical drug development.[ Price : $8.95]
The Senate Special Committee on Aging chairman and ranking member ask the Government Accountability Office to study and assess any...[ Price : $8.95]
Consultants RMS suggests ways that companies can reduce the impact and risk of FDA complete response letters.